| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/20/1997 | WO1997009992A1 Lipid extract having anti-inflammatory activity |
| 03/20/1997 | WO1997009990A1 Transdermal therapeutical system for silatran compounds |
| 03/20/1997 | WO1997009989A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 03/20/1997 | WO1997009988A1 A biologically active preparation containing vinylene ethonium and decamethoxin |
| 03/20/1997 | WO1997009987A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 03/20/1997 | WO1997009986A1 Pge1-containing freeze-dried preparation and process for the production thereof |
| 03/20/1997 | WO1997009985A1 Transdermal administration of olanzapine |
| 03/20/1997 | WO1997009984A1 Immunosuppressant |
| 03/20/1997 | WO1997009982A1 Nitrogen monoxide synthetase inhibitor comprising 2-aminopyridines as active ingredient |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | WO1997009980A1 Pharmaceutical formulations containing darifenacin |
| 03/20/1997 | WO1997009978A1 Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them |
| 03/20/1997 | WO1997009977A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 03/20/1997 | WO1997009976A2 Method of reducing neurotoxic injury with zinc chelators |
| 03/20/1997 | WO1997009975A1 Topical anti-skin-cancer preparations |
| 03/20/1997 | WO1997009974A1 Antiseptic skin care composition and method for making same |
| 03/20/1997 | WO1997009973A2 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 03/20/1997 | WO1997009968A1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 03/20/1997 | WO1997009965A1 A NON-IRRITATING SKIN AND HAIR REJUVENATING COMPOSITION HAVING A pH BETWEEN 1 AND 6.5 |
| 03/20/1997 | WO1997009963A1 Skin peel maintenance composition and method |
| 03/20/1997 | WO1997009960A1 Composition and method for treating diseased nails |
| 03/20/1997 | WO1997009889A1 Cancer chemoprotective food products |
| 03/20/1997 | WO1997009885A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration |
| 03/20/1997 | WO1997009877A1 CURCUMIN (DIFERULOYLMETHANE) INHIBITION OF NFλB ACTIVATION |
| 03/20/1997 | WO1997006807A3 Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation |
| 03/20/1997 | WO1997003660A3 Modulation of protein phosphatase activity and uses relating to fertility and contraception |
| 03/20/1997 | WO1997003654A3 Pharmaceutical compositions |
| 03/20/1997 | DE19535571A1 Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten Pharmaceutical combination preparations and their use for the treatment of hemodialysis patients |
| 03/20/1997 | DE19534201A1 Zubereitung zur Prophylaxe und/oder Behandlung von Woll- und Haarausfall Preparation for the prophylaxis and / or treatment of wool and hair loss |
| 03/20/1997 | CA2593316A1 Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/20/1997 | CA2368867A1 Cancer chemoprotective food products |
| 03/20/1997 | CA2356097A1 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | CA2232262A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration |
| 03/20/1997 | CA2232161A1 Diarylalkenylamine derivatives |
| 03/20/1997 | CA2232089A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | CA2232082A1 Naphthamide derivatives of 3 .beta.-amino azabicyclo octane or nonane as neuroleptic agents |
| 03/20/1997 | CA2232081A1 Antiseptic skin care composition and method for making same |
| 03/20/1997 | CA2232059A1 Phenol derivatives with pharmaceutical activity |
| 03/20/1997 | CA2232050A1 Method for measuring nitrosyl (feii)-hemoglobin |
| 03/20/1997 | CA2232048A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | CA2232033A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | CA2232026A1 Transdermal therapeutical system for silatran compounds |
| 03/20/1997 | CA2232012A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | CA2232007A1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists |
| 03/20/1997 | CA2232002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | CA2232000A1 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | CA2231998A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | CA2231996A1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 03/20/1997 | CA2231848A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| 03/20/1997 | CA2231769A1 Composition and method for treating diseased nails |
| 03/20/1997 | CA2231768A1 L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 03/20/1997 | CA2231687A1 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 03/20/1997 | CA2231685A1 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | CA2231682A1 Pge1-containing freeze-dried preparation and the production thereof |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/20/1997 | CA2231164A1 Esters of non-steroidal anti-inflammatory carboxylic acids |
| 03/20/1997 | CA2231041A1 4-azasteroids for treatment of hyperandrogenic conditions |
| 03/20/1997 | CA2231003A1 Benzothiazolone derivatives |
| 03/20/1997 | CA2230970A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 03/20/1997 | CA2230122A1 Pyrrolidine and thiazole derivatives with antibacterial and metallo-beta-lactamase inhibitory properties |
| 03/20/1997 | CA2229435A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 03/20/1997 | CA2226915A1 Immunosuppressant |
| 03/20/1997 | CA2204002A1 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 03/20/1997 | CA2185850A1 2-cyano-3-mercaptocrotonamides |
| 03/19/1997 | EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives |
| 03/19/1997 | EP0763537A2 Non-peptidyl Ras farnesyl transferase inhibitors |
| 03/19/1997 | EP0763536A1 Process for producing 6-aminomethyl-substituted quinoline-benzoic acids |
| 03/19/1997 | EP0763535A1 Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds |
| 03/19/1997 | EP0763534A1 Arylalkyl-diazinone derivatives as phosphodiesterase IV inhibitors |
| 03/19/1997 | EP0763527A1 Substituted 2,2-dimethyl-omega-phenoxy alkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763524A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use |
| 03/19/1997 | EP0763362A2 A pharmaceutical base in ointment form and its use |
| 03/19/1997 | EP0763359A1 Pharmaceutical composition for topical use |
| 03/19/1997 | EP0763358A1 Buccal delivery system for therapeutic agents |
| 03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
| 03/19/1997 | EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy |
| 03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763053A1 Steroid derivatives for treatment of 5 alpha reductase |
| 03/19/1997 | EP0763052A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 03/19/1997 | EP0763051A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
| 03/19/1997 | EP0763050A1 Branched oligonucleotides as pathogen-inhibitory agents |
| 03/19/1997 | EP0763049A1 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 03/19/1997 | EP0763048A1 Post exposure prevention of hiv |
| 03/19/1997 | EP0763042A1 Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents |
| 03/19/1997 | EP0763041A1 Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents |
| 03/19/1997 | EP0763040A1 Carbazole derivatives as agents against multi-drug resistance |
| 03/19/1997 | EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763038A1 The preparation of nalbuphine having low levels of beta-epimer |
| 03/19/1997 | EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763035A1 Endothelin receptor antagonists |
| 03/19/1997 | EP0763034A1 Amide derivatives having 5ht1d-antagonist activity |
| 03/19/1997 | EP0763033A1 Imidazole derivatives and processes for the preparation thereof |
| 03/19/1997 | EP0763032A1 Palladium catalyzed ring closure of triazolyl tryptamine |
| 03/19/1997 | EP0763031A1 Piperazine derivatives as 5ht1a antagonists |
| 03/19/1997 | EP0763026A1 Gastrin and cck antagonists |
| 03/19/1997 | EP0763022A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and thiomorpholines as calcium channel antagonists |